Checkpoint Kinase 1 (CHK1) Functions as Both a Diagnostic Marker and a Regulator of Epithelial-to-Mesenchymal Transition (EMT) in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is more difficult to treat and has a higher mortality rate than other subtypes. Although hormone receptor-targeted therapy is an effective treatment to increase survival rate in breast cancer patients, it is not suitable for TNBC patients. To address the issues,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyo-Jin, Seo, Bo-Gyeong, Seo, Eun-Chan, Lee, Kwang-Min, Hwangbo, Cheol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777496/
https://www.ncbi.nlm.nih.gov/pubmed/36547059
http://dx.doi.org/10.3390/cimb44120398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777496/
https://www.ncbi.nlm.nih.gov/pubmed/36547059
http://dx.doi.org/10.3390/cimb44120398

Ejemplares similares